rs3811003
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001232.4(CASQ2):c.939+23C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.332 in 1,440,028 control chromosomes in the GnomAD database, including 83,796 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 12731 hom., cov: 33)
Exomes 𝑓: 0.33 ( 71065 hom. )
Consequence
CASQ2
NM_001232.4 intron
NM_001232.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.198
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-115705169-G-A is Benign according to our data. Variant chr1-115705169-G-A is described in ClinVar as [Benign]. Clinvar id is 257653.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115705169-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.558 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.389 AC: 59140AN: 152026Hom.: 12719 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
59140
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.346 AC: 86909AN: 251060 AF XY: 0.338 show subpopulations
GnomAD2 exomes
AF:
AC:
86909
AN:
251060
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.326 AC: 419445AN: 1287882Hom.: 71065 Cov.: 19 AF XY: 0.323 AC XY: 210046AN XY: 650278 show subpopulations
GnomAD4 exome
AF:
AC:
419445
AN:
1287882
Hom.:
Cov.:
19
AF XY:
AC XY:
210046
AN XY:
650278
Gnomad4 AFR exome
AF:
AC:
16994
AN:
30080
Gnomad4 AMR exome
AF:
AC:
16196
AN:
44516
Gnomad4 ASJ exome
AF:
AC:
6914
AN:
25072
Gnomad4 EAS exome
AF:
AC:
18614
AN:
38868
Gnomad4 SAS exome
AF:
AC:
24276
AN:
82944
Gnomad4 FIN exome
AF:
AC:
15740
AN:
53360
Gnomad4 NFE exome
AF:
AC:
300031
AN:
953072
Gnomad4 Remaining exome
AF:
AC:
18715
AN:
54640
Heterozygous variant carriers
0
13545
27090
40636
54181
67726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
9444
18888
28332
37776
47220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.389 AC: 59194AN: 152146Hom.: 12731 Cov.: 33 AF XY: 0.388 AC XY: 28861AN XY: 74380 show subpopulations
GnomAD4 genome
AF:
AC:
59194
AN:
152146
Hom.:
Cov.:
33
AF XY:
AC XY:
28861
AN XY:
74380
Gnomad4 AFR
AF:
AC:
0.563681
AN:
0.563681
Gnomad4 AMR
AF:
AC:
0.335971
AN:
0.335971
Gnomad4 ASJ
AF:
AC:
0.290081
AN:
0.290081
Gnomad4 EAS
AF:
AC:
0.509694
AN:
0.509694
Gnomad4 SAS
AF:
AC:
0.291632
AN:
0.291632
Gnomad4 FIN
AF:
AC:
0.315899
AN:
0.315899
Gnomad4 NFE
AF:
AC:
0.309158
AN:
0.309158
Gnomad4 OTH
AF:
AC:
0.369915
AN:
0.369915
Heterozygous variant carriers
0
1805
3610
5415
7220
9025
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1328
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Catecholaminergic polymorphic ventricular tachycardia 2 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at